Terms: = Breast cancer AND PHOX2B, 8929 AND Treatment
2 results:
1. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
[TBL] [Abstract] [Full Text] [Related]
2. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Ichou FA; den Ouden E; Versteeg R; Caron HN; Tytgat GA; van der Schoot CE
Clin Cancer Res; 2012 Feb; 18(3):808-14. PubMed ID: 22142825
[TBL] [Abstract] [Full Text] [Related]